Bronchial atypical carcinoid tumor without invasion but with marked intraluminal growth like branchial tree cast

Respiratory Medicine CME

Volumn 3, Issue 3, 2010, Pages 179-182

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Atypical carcinoid; Intrabronchial growth; Lung

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN;

ADULT; ARTICLE; BRONCHUS CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG LOBE; LYMPH NODE DISSECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPUTUM; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TREE; TRANSBRONCHIAL BIOPSY; ULTRASOUND;

EID: 78549294836     PISSN: 17550017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedc.2009.07.004     Document Type: Article

References (15)

1. Beasley M.B., Geisinger K., Thunneissen F.B., et al. Carcinoid tumour. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura and heart 2004, 59-62. IARC Press, Ryon. W.D. Travis, E. Blambillia, K. Muller-Hermelink, C.C. Harris (Eds.).
2. Van Boxem T.J., Golding R.P., Venmans B.J., Postmus P.E., Sutedja T.G. High-resolution CT in patients with intraluminal typical carcinoid tumors treated with bronchoscopic therapy. Chest 2000, 117:125-128.
3. Sutedja T.G., Schreurs A.J., Vanderschueren R.G., Kwa B., vd WElf T.S., Portmus P.E. Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest 1995, 107:556-568.
4. Brokx H.A., Risse E.K., Paul M.A., Grunbern K., Golding R.P., Kunst P.W., et al. Initial chronchoscopic treatment for patients with intraluminal chronchial carcinoids. J Thrac Cardiovas Surg 2007, 133:973-978.
5. Terada T., Kawaguchi M., Furukawa K., Sekido Y., Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 2002, 52:740-746.
6. Terada T., Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 2005, 271:271-275.
7. Travis W.D., Rush W., Flieder D.B., Falk R., Fleming M.V., Gal A.A., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with classification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998, 22:934-944.
8. Soga J., Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1,875 reported cases with special references to the comparison between typical carcinoids and atypical varieties. Ann Thrac Cardiovasc Surg 1999, 5:211-219.
9. Olliaro A., Filosso P.L., Donati G., Ruffini E. Atypical bronchial carcinoid: review of 46 patients. J Cardiovas Surg 2000, 41:131-135.
10. Gould V.E., Linnnoila R.I., Memoli V.A., Warren W.H. Neuroendocrine components of the bronchopulmonary tract: hyperplasia, dysplasia, and neoplasms. Lab Invest 1983, 49:519-537.
11. Sidhu G. The endodermal origin of digestive and respiratory tract APUD cells: histopathologic evidence and a review of the literature. Am J Pathol 1979, 96:5-20.
12. Salyer D.C., Salyer W.R., Eggleston J.C. Bronchial carcinoid tumors. Cancer 1975, 36:1522-1537.
13. Endo K., Ohta T., Terada T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters and patients' survival. Hum Pathol 2000, 31:558-565.
14. Terada T., Ashida K., Kitamura Y., Matsunaga Y., Takashima K., Kato M., et al. Expression of E-cadherin, alpha-catenin and beta-catenin during human intrahepatic bile duct development. J Hepatol 1998, 28:263-269.
15. Terada T., Okada Y., Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996, 23:1341-1344.